'Unjustified' thrombolysis in patients with suspected myocardial infarction;'Unberechtigte' thrombolyse bei suspektem myokardinfarkt

Wiener Klinische Wochenschrift

Volumn 112, Issue 21, 2000, Pages 912-916

  Schreiber, W ^a   Pieper, O ^a   Herkner, H ^a   Laggner, A N ^a   Huber, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

'Unjustified' thrombolysis; Myocardial infarction

Indexed keywords

CREATINE KINASE; FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BRADYCARDIA; CREATINE KINASE BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; ST SEGMENT DEPRESSION; AUSTRIA; BLOOD; DIAGNOSTIC ERROR; ELECTROCARDIOGRAPHY; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

AGED; AUSTRIA; CREATINE KINASE; DIAGNOSTIC ERRORS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 0034634267     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
3. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction
4. Guidelines for the management of patients with acute myocardial infarction
5. Time as an adjunctive agent to thrombolytic therapy
6. Myocardial infarction and coronary deaths in the world health organization MONICA project
7. Risk identification at the time of admission to the coronary care unit in patients with suspected myocardial infarction
8. Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction
9. Very early thrombolytic therapy in suspected acute myocardial infarction
10. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
11. 'Inadvertent' thrombolytic administration in patients without myocardial infarction: Clinical features and outcome
12. Prediction of early complications in patients with acute myocardial infarction by calculation of the ST score
13. Electrocardiographic and clinical criteria for recognation of acute myocardial infarction based on analysis of 3697 patients
14. Evaluation of ST segment elevation criteria for the prehospital electrocardiographic diagnosis of acute myocardial infarction
15. Detection of unsuspected myocardial necrosis by rapid bedside assay fur cardiac troponin T
16. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponin I and T for acute myocardial infarction
17. Thrombolysis in unstable angina - Randomized double-blind trial of t-PA and placebo
18. Randomized trial of thrombolysis versus heparin in unstable angina
19. Die rolle der praklinischen thrombose bei der therapie des akuten myokardinfarkts
20. A comparison of reteplase with alteplase for acute myocardial infarction
21. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
22. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial
23. Outcome after thrombolytic therapy of nine cases of myopericarditis misdiagnosed as myocardial infarction
24. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
25. ISIS 3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41.299 cases of suspected acute myocardial infarction
26. Emergency department: Rapid identification and treatment of patients with acute myocardial infarction